Dongwha Pharm.Co.Ltd (000020) - Total Liabilities

Latest as of December 2025: ₩240.73 Billion KRW ≈ $163.14 Million USD

Based on the latest financial reports, Dongwha Pharm.Co.Ltd (000020) has total liabilities worth ₩240.73 Billion KRW (≈ $163.14 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Dongwha Pharm.Co.Ltd (000020) cash conversion ratio to assess how effectively this company generates cash.

Dongwha Pharm.Co.Ltd - Total Liabilities Trend (2011–2025)

This chart illustrates how Dongwha Pharm.Co.Ltd's total liabilities have evolved over time, based on quarterly financial data. Check 000020 asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Dongwha Pharm.Co.Ltd Competitors by Total Liabilities

The table below lists competitors of Dongwha Pharm.Co.Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Orian Sh.M. Ltd TA:ORIN	Israel	ILA1.30 Billion
Bcl Industries Limited NSE:BCLIND	India	Rs7.94 Billion
Bridger Aerospace Group Holdings, Inc. Common Stock NASDAQ:BAER	USA	$233.06 Million
Diploma PLC LSE:DPLM	UK	GBX862.60 Million
Celik Halat ve Tel Sanayi AS IS:CELHA	Turkey	TL1.63 Billion
Calitech Co Ltd TWO:6532	Taiwan	NT$271.10 Million
Waldencast Acquisition Corp NASDAQ:WALD	USA	$316.10 Million

Liability Composition Analysis (2011–2025)

This chart breaks down Dongwha Pharm.Co.Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Dongwha Pharm.Co.Ltd market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.07	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.63	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.37	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Dongwha Pharm.Co.Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Dongwha Pharm.Co.Ltd (2011–2025)

The table below shows the annual total liabilities of Dongwha Pharm.Co.Ltd from 2011 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩240.73 Billion ≈ $163.14 Million	+10.45%
2024-12-31	₩217.96 Billion ≈ $147.71 Million	+38.02%
2023-12-31	₩157.92 Billion ≈ $107.02 Million	+91.50%
2022-12-31	₩82.46 Billion ≈ $55.88 Million	-5.94%
2021-12-31	₩87.67 Billion ≈ $59.41 Million	-3.79%
2020-12-31	₩91.13 Billion ≈ $61.75 Million	+21.25%
2019-12-31	₩75.15 Billion ≈ $50.93 Million	+2.67%
2018-12-31	₩73.20 Billion ≈ $49.61 Million	+4.15%
2017-12-31	₩70.28 Billion ≈ $47.63 Million	-1.95%
2016-12-31	₩71.68 Billion ≈ $48.58 Million	-17.68%
2015-12-31	₩87.07 Billion ≈ $59.01 Million	+4.47%
2014-12-31	₩83.35 Billion ≈ $56.48 Million	-6.28%
2013-12-31	₩88.93 Billion ≈ $60.27 Million	-8.59%
2012-12-31	₩97.29 Billion ≈ $65.93 Million	-11.40%
2011-12-31	₩109.81 Billion ≈ $74.42 Million	--

About Dongwha Pharm.Co.Ltd

KO:000020 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$113.83 Million

₩167.97 Billion KRW

Market Cap Rank

#18692 Global

#968 in Korea

Share Price

₩6060.00

Change (1 day)

-0.49%

52-Week Range

₩5660.00 - ₩7060.00

All Time High

₩28554.43